Anatara Lifesciences Ltd

CHIA:ANR Stock Report

Market Cap: AU$8.7m

Anatara Lifesciences Management

Management criteria checks 4/4

We currently do not have sufficient information about the CEO.

Key information

David Brookes

Chief executive officer

AU$172.9k

Total compensation

CEO salary percentage86.7%
CEO tenure5.9yrs
CEO ownership0.6%
Management average tenure2.5yrs
Board average tenure6yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has David Brookes's remuneration changed compared to Anatara Lifesciences's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024AU$173kAU$150k

-AU$1m

Mar 31 2024n/an/a

-AU$2m

Dec 31 2023n/an/a

-AU$2m

Sep 30 2023n/an/a

-AU$2m

Jun 30 2023AU$198kAU$152k

-AU$2m

Mar 31 2023n/an/a

-AU$2m

Dec 31 2022n/an/a

-AU$2m

Sep 30 2022n/an/a

-AU$2m

Jun 30 2022AU$150kAU$108k

-AU$3m

Mar 31 2022n/an/a

-AU$2m

Dec 31 2021n/an/a

-AU$2m

Sep 30 2021n/an/a

-AU$2m

Jun 30 2021AU$84kn/a

-AU$2m

Mar 31 2021n/an/a

-AU$2m

Dec 31 2020n/an/a

-AU$3m

Sep 30 2020n/an/a

-AU$3m

Jun 30 2020AU$80kn/a

-AU$3m

Mar 31 2020n/an/a

-AU$3m

Dec 31 2019n/an/a

-AU$3m

Sep 30 2019n/an/a

-AU$3m

Jun 30 2019AU$35kn/a

-AU$3m

Compensation vs Market: David's total compensation ($USD107.30K) is below average for companies of similar size in the Australian market ($USD288.99K).

Compensation vs Earnings: David's compensation has been consistent with company performance over the past year.

CEO

David Brookes (64 yo)

5.9yrs

Tenure

AU$172,911

Compensation

Dr. David Lionel Brookes, MBBS, FACRRM, FAICD, served as an Independent Non-Executive Director of Island Pharmaceuticals Limited since October 1, 2020 until September 19, 2024. He serves as Managing Direct...

Leadership Team

NamePositionTenureCompensationOwnership
David Brookes
Executive Chairman & MDno dataAU$172.91k0.55%
A$ 48.3k
John Michailidis
COO & Executive Director2.5yrsAU$170.79k0.58%
A$ 50.4k
Simon Erskine
Chief Development Officer3.1yrsAU$289.40kno data
Jonathan Lindh
Company Secretaryless than a yearno datano data
Hayley van der Meer
Commercial Managerno datano datano data

2.5yrs

Average Tenure

Experienced Management: ANR's management team is considered experienced (2.5 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
David Brookes
Executive Chairman & MD5.9yrsAU$172.91k0.55%
A$ 48.3k
John Michailidis
COO & Executive Director1.2yrsAU$170.79k0.58%
A$ 50.4k
Peter Gibson
Chairman of Product Development Advisory Board6yrsno datano data
Rebecca Burgell
Member of Product Development Advisory Board6yrsno datano data
Jakob Begun
Member of Product Development Advisory Board6yrsno datano data
Barry Campbell
Member of Product Development Advisory Board6yrsno datano data
Simon Keely
Member of Product Development Advisory Board6yrsno datano data
Nicholas Haslam
Non-Executive Director2yrsAU$66.60kno data

6.0yrs

Average Tenure

Experienced Board: ANR's board of directors are considered experienced (6 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/27 05:42
End of Day Share Price 2024/12/13 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Anatara Lifesciences Ltd is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Paul JenszPAC Partners Securities Pty. Ltd.
Shane StoreyWilsons Advisory and Stockbroking Ltd.